Aggressive fibromatosis of the neck treated with a combination of chemotherapy and indomethacin.
Longhi A, Errani C, Battaglia M, Alberghini M, Ferrari S, Mercuri M, Molinari M.
Ear Nose Throat J. 2011 Jun;90(6):E11-5. doi: 10.1177/014556131109000610.
The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
Lips DJ, Barker N, Clevers H, Hennipman A.
Eur J Surg Oncol. 2009 Jan;35(1):3-10. doi: 10.1016/j.ejso.2008.07.003. Epub 2008 Aug 21.
Control of aggressive fibromatosis by treatment with imatinib mesylate. A case report and review of the literature.
Wcislo G, Szarlej-Wcislo K, Szczylik C.
J Cancer Res Clin Oncol. 2007 Aug;133(8):533-8. doi: 10.1007/s00432-007-0198-9. Epub 2007 Apr 24.
Sorafenib or anthracycline-based chemotherapy for progressive desmoid tumors.
Costa PA, Arora A, Fernandez Y, Yi I, Bakkila B, Tan H, Barreto Coelho P, Campoverde L, Hardy N, Bialick S, Espejo Freire A, D'Amato GZ, Chang YC, Mesenger JP, Subhawong T, Haims A, Hurwitz M, Olino K, Turaga K, Deshpande H, Trent J.
Cancer. 2025 Jan 1;131(1):e35647. doi: 10.1002/cncr.35647. Epub 2024 Nov 14.
Ledderhose's Disease: An Up-to-Date Review of a Rare Non-Malignant Disorder.
Tomac A, Ion AP, Opriș DR, Arbănași EM, Ciucanu CC, Bandici BC, Coșarcă CM, Covalcic DC, Mureșan AV.
Clin Pract. 2023 Sep 28;13(5):1182-1195. doi: 10.3390/clinpract13050106.
Clinical features and management of superficial fibromatoses.
Kelenjian S, Mattjie RA, Franz R, Biedermann T, Brockow K.
J Dtsch Dermatol Ges. 2019 Apr;17(4):393-397. doi: 10.1111/ddg.13808. Epub 2019 Mar 13.
Desmoid tumor of the hand: a case report.
Maher J, Smith DA, Parker WL.
Ann Plast Surg. 2014 Oct;73(4):390-2. doi: 10.1097/SAP.0b013e31827f4dea.
Reactive bone lesions mimicking neoplasms.
Hoch B, Montag A.
Semin Diagn Pathol. 2011 Feb;28(1):102-12. doi: 10.1053/j.semdp.2011.02.011.
Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Shimizu K, Kawashima H, Kawai A, Yoshida M, Nishida Y.
Jpn J Clin Oncol. 2020 Oct 22;50(11):1274-1281. doi: 10.1093/jjco/hyaa125.
A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis.
Jo JC, Hong YS, Kim KP, Lee JL, Lee J, Park YS, Kim SY, Ryu JS, Lee JS, Kim TW.
Invest New Drugs. 2014 Apr;32(2):369-76. doi: 10.1007/s10637-013-0059-0. Epub 2014 Jan 16.
